The Treatment of Post-Encephalitig Parkinsonism by Nicotine.
作者信息
Moll H
出版信息
Br Med J. 1926 Jun 26;1(3416):1079-81. doi: 10.1136/bmj.1.3416.1079.
Abstract
摘要
相似文献
1
The Treatment of Post-Encephalitig Parkinsonism by Nicotine.
Br Med J. 1926 Jun 26;1(3416):1079-81. doi: 10.1136/bmj.1.3416.1079.
2
The action on nicotine-induced tremors of substances effective in Parkinsonism.
J Pharmacol Exp Ther. 1951 May;102(1):22-30.
3
Effects of nicotine chewing gum on UPDRS score and P300 in early-onset parkinsonism.
Hiroshima J Med Sci. 2002 Mar;51(1):33-9.
4
RESERPINE-NICOTINE INDUCED PARKINSONISM IN MICE.
Arch Int Pharmacodyn Ther. 1965 Mar;154:69-81.
5
Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism.
Free Radic Biol Med. 2013 Dec;65:704-718. doi: 10.1016/j.freeradbiomed.2013.07.042. Epub 2013 Aug 7.
6
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism.
J Neural Transm (Vienna). 1997;104(10):1113-23. doi: 10.1007/BF01273324.
7
Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors.
J Neurochem. 1998 Dec;71(6):2439-46. doi: 10.1046/j.1471-4159.1998.71062439.x.
8
[Antagonism of dibenzothiazine derivatives (diparcol, parsidol, phenergan) towards the central effects of nicotine; correspondence with clinical experimentation in Parkinson's disease].
C R Seances Soc Biol Fil. 1950 Apr;144(7-8):514-7.
9
[Neuroleptics and nicotine].
Psychiatr Prax. 1995 Nov;22(6):223-7.
10
[Nicotine in neuropsychiatric movement disorders].
Fortschr Neurol Psychiatr. 1996 Sep;64(9):362-6. doi: 10.1055/s-2007-996579.
引用本文的文献
1
Unhealthy Behaviours and Risk of Parkinson's Disease: A Mendelian Randomisation Study.
J Parkinsons Dis. 2021;11(4):1981-1993. doi: 10.3233/JPD-202487.
2
In Vitro and In Silico Analyses of Nicotine Release from a Gelisphere-Loaded Compressed Polymeric Matrix for Potential Parkinson's Disease Interventions.
Pharmaceutics. 2018 Nov 15;10(4):233. doi: 10.3390/pharmaceutics10040233.
3
Therapeutic Applications of Nicotinic Stimulation: Successes, Failures, and Future Prospects.
Nicotine Tob Res. 2019 Feb 18;21(3):345-348. doi: 10.1093/ntr/nty189.
4
Nicotine from cigarette smoking and diet and Parkinson disease: a review.
Transl Neurodegener. 2017 Jul 2;6:18. doi: 10.1186/s40035-017-0090-8. eCollection 2017.
5
Chronic Nicotine Mitigates Aberrant Inhibitory Motor Learning Induced by Motor Experience under Dopamine Deficiency.
J Neurosci. 2016 May 11;36(19):5228-40. doi: 10.1523/JNEUROSCI.2754-15.2016.
6
Beta2* and beta4* nicotinic acetylcholine receptor expression changes with progressive parkinsonism in non-human primates.
Neurobiol Dis. 2007 Sep;27(3):312-9. doi: 10.1016/j.nbd.2007.06.004. Epub 2007 Jun 13.
7
Medicinal uses of tobacco in history.
J R Soc Med. 2004 Jun;97(6):292-6. doi: 10.1177/014107680409700614.
8
Effect of acute nicotine administration on striatal dopamine output and metabolism in rats kept at different ambient temperatures.
Br J Pharmacol. 2000 Jul;130(5):1147-55. doi: 10.1038/sj.bjp.0703402.
9
Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
Drugs Aging. 1997 Sep;11(3):206-28. doi: 10.2165/00002512-199711030-00005.
10
Nicotine may relieve symptoms of Parkinson's disease.
Psychopharmacology (Berl). 1994 Sep;116(1):117-9. doi: 10.1007/BF02244882.
本文引用的文献
1
A British Medical Association Lecture on Post-Encephalitic Parkinsonism.
Br Med J. 1926 Jan 23;1(3395):127-30. doi: 10.1136/bmj.1.3395.127.
Zotero 插件